rheum Q&As

Q&As

4 Questions About Patient Perceptions of MTX Use in RA, PsA

02/10/2020

Methotrexate (MTX), although a frequently used therapy for rheumatoid arthritis (RA) and psoriatic arthritis (PsA), is associated with potential adverse effects and tolerability issues. Additionally, there is a...

...

02/10/2020

Rheumatology & Arthritis

Q&As

5 Questions About IBS and Axial Spondyloarthritis

01/28/2020

More than half of all patients with ankylosing spondylitis (AS) report frequent gut pain and diarrhea. However, while microscopic gut inflammation is common in this disease, such inflammation has not been clearly...

More...

01/28/2020

Rheumatology & Arthritis

Q&As

4 Questions About the Global Burden of Rheumatoid Arthritis

01/22/2020

Rheumatoid arthritis (RA) is a major public health challenge and significantly contributes to global disability. In a recent study, Marita Cross, PhD, a research fellow from the Institute of Bone and Joint...

...

01/22/2020

Rheumatology & Arthritis

Q&As

5 Questions About Interstitial Lung Disease in Systemic JIA

12/27/2019

Interstitial lung disease—also known as diffuse parenchymal lung disease—is increasingly found in children with systemic juvenile idiopathic arthritis (JIA). The reason behind the rising prevalence of the lung disease...

...

12/27/2019

Rheumatology & Arthritis

Q&As

4 Questions About Smoking and Acute Anterior Uveitis Incidence in AxSpA

12/26/2019

Acute anterior uveitis (AAU) is the most common extra-axial manifestation of axial spondyloarthritis (axSpA). Research on axSpA has shown a lower likelihood of AAU in current smokers than former smokers or those who...

Acute...

12/26/2019

Rheumatology & Arthritis

Q&As

4 Questions About Genetic Testing in the Diagnosis of Psoriatic Arthritis

12/25/2019

Determining whether genetic testing can be used to predict the diagnosis of psoriatic arthritis (PsA) by a rheumatologist in a clinical setting is important, considering the reduced costs of genetic testing and the...

...

12/25/2019

Rheumatology & Arthritis

Q&As

4 Questions About Bone Mineral Density in Psoriatic Arthritis

12/18/2019

Research on the effect of psoriatic arthritis (PsA) on bone mineral density (BMD) is inconsistent. A recent systematic review found the studies to be of high heterogeneity, small in numbers, and yielding...

...

12/18/2019

Rheumatology & Arthritis

Q&As

4 Questions About Inhibitor of DNA Binding 1 Protein in Rheumatoid Arthritis

11/27/2019

Inhibitor of DNA binding 1 (ID-1) is a nuclear transcription factor that controls transcriptional activation of target genes. Previous research indicates that ID-1 may contribute to angiogenesis and vasculogenesis...

...

11/27/2019

Rheumatology & Arthritis

Q&As

4 Questions About Liver Abnormalities in Psoriatic Arthritis

11/04/2019

Psoriasis and psoriatic arthritis (PsA) have been associated with a number of metabolic comorbidities. Research regarding liver disease and liver abnormalities in PsA is limited. Findings of a new study by Dafna...

...

11/04/2019

Rheumatology & Arthritis

Q&As

5 Questions About Therapeutic Targets in Osteoarthritis Management

10/30/2019

Over time, management strategies for osteoarthritis (OA) have shifted from traditional approaches of focusing only on pain control to interventions which also focus on improving functional activity and quality of life....

Over...

10/30/2019

Rheumatology & Arthritis

Q&As

Stay in the Know

Partner Spotlight

Popular Articles

Specialties

Events

Year Round Education

HMP Global Products